vitro activity sparfloxacin clinical Legionella isolates pharmacokinetics guinea pigs use guinea pigs pneumophila pneumonia activities sparfloxacin ciprofloxacin erythromycin clinical Legionella isolates agar dilution susceptibility growth inhibition assays guinea pig alveolar macrophages sparfloxacin ciprofloxacin antimicrobial agents equivalent activities charcoal yeast extract medium alpha-ketoglutarate test medium MICs strains micrograms/ml erythromycin sparfloxacin microgram/ml ciprofloxacin Buffered charcoal yeast extract medium alpha-ketoglutarate activities antimicrobial agents susceptibility control Staphylococcus strain Broth macrodilution MICs pneumophila strains buffered yeast extract alpha-ketoglutarate equal microgram/ml sparfloxacin microgram/ml ciprofloxacin microgram/ml erythromycin erythromycin medium Ciprofloxacin sparfloxacin microgram/ml bacterial counts pneumophila strains guinea pig alveolar macrophages CFU/ml regrowth period Sparfloxacin ciprofloxacin microgram/ml postantibiotic effect Pharmacokinetic therapy studies sparfloxacin guinea pigs pneumophila pneumonia pharmacokinetic study sparfloxacin mg/kg body weight guinea pigs intraperitoneal route peak levels serum lung micrograms/ml micrograms/g terminal-phase half-life elimination serum 